Moreover, the analysis of resection specimen obtained from glioblastoma patients after treatment with EGFRvIII-specific CAR-T cells revealed, among others, strong PD-L1 upregulation, providing clinical corroboration for the relevance of the PD-1/PD-L1 axis in glioma [84,85]. This evidence concerns the gene CD274 and glioma.